WallStSmart
APLT

Applied Therapeutics Inc

NASDAQ: APLT · HEALTHCARE · BIOTECHNOLOGY

$0.10
+0.00% today

Updated 2026-04-29

Market cap
$14.86M
P/E ratio
—
P/S ratio
14.86x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$0 – $2
Volume
2.7M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Applied Therapeutics Inc (APLT) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item20172018201920202021202220232024
Revenue$0.00$0.00$0.00$0.00$0.00$10.66M$9.99M$455000.00
Revenue growth (YoY)——————-6.3%-95.4%
Cost of revenue$0.00$0.00$23000.00$380000.00$415000.00$441000.00$53.91M$48.74M
Gross profit$0.00$0.00$-23000.00$-380000.00$-415000.00$-441000.00$-43.91M$-48.29M
Gross margin—————-4.1%-439.4%-10613.0%
R&D$3.70M$11.47M$32.35M$61.79M$62.57M$55.63M$53.91M$48.74M
SG&A$582000.00$2.05M$13.23M$32.68M$43.05M$27.32M$20.12M$55.46M
Operating income$-4.29M$-13.52M$-45.58M$-94.47M$-105.62M$-82.95M$-64.53M$-104.30M
Operating margin—————-778.1%-645.8%-22922.9%
EBITDA$-4.29M$-3.00M$-45.56M$-94.09M$-105.20M$-82.07M$-64.53M$-104.30M
EBITDA margin—————-769.9%-645.8%-22922.6%
EBIT$-4.29M$-16.52M$-45.58M$-94.47M$-105.62M$-82.51M$-64.53M$-104.30M
Interest expense$0.00$0.00$93000.00$559000.00$555000.00$442000.00——
Income tax$-4.29M$4.87M$-116000.00$-939000.00$-970000.00$-819000.00$185105.00—
Effective tax rate50.0%-41.8%0.3%1.0%0.9%1.0%-0.2%0.0%
Net income$-4.28M$-16.52M$-45.40M$-93.02M$-104.61M$-82.51M$-119.76M$-105.62M
Net income growth (YoY)—-285.8%-174.8%-104.9%-12.5%+21.1%-45.2%+11.8%
Profit margin—————-774.0%-1198.5%-23214.1%